Healthy Societies

Article Recession’s health repercussions

This article explores how recessions impact health and inhibit system resilience

Report Global Risks Report 2023

Tougher trade-offs risk eroding climate action, human development and future resilience.

Report Life support: a people prescription for resilient health systems

This report explores characteristics of resilience at the healthcare system level, factors undermining resilience, and ways forward as healthcare providers emerge from the COVID-19 pandemic.

Perspective Pharma's Opportunity to Impact Health Equity

Pharmaceutical companies are uniquely positioned to impact health equity. It must become a corporate priority and engrained in the product life cycle

Perspective Health Equity is a Business and Moral Imperative

The message from state and federal regulators is clear: Addressing health equity is no longer a choice for insurers, it is a part of doing business with Medicare and Medicaid

Report Global insurer survey report: MMB Health trends 2023

Navigating cost trends and using innovation in employer-provided healthcare

Perspective What We Now Know About Long COVID – And What To Do About It

Perspective Economic Conditions Reshape Private Equity Deal Making

Despite a slowdown in deal making, pharmaceuticals and healthtech continue to get attention from investors.

Perspective Health Benefit Cost Growth Will Accelerate to 5.6% in 2023

Healthcare affordability is an issue for many employees, especially with inflation stressing household budgets. Employers are trying to keep more money in employees' paychecks and remove cost barriers when care is needed.

Report Fulfilling a Legacy of Societal Risk Management

This initiative applies five core insurance sector capabilities to a series of innovative Pioneer Projects that illustrate the power of insurance in risk reduction efforts.

Journal Digital Health Compendium

A selection of perspectives from experts across our businesses on risk, people, and strategy issues at the intersection of transformative technologies and health. The compendium explores opportunities and risks for healthcare and health technology providers, insurers, and employers.

Article Artificial Intelligence in Life Sciences: An Evolving Risk Landscape

While AI yields tremendous benefits, the technological risks are wide-ranging and complex. This article examines the key risks – and measures to counter them.

Article Artificial Intelligence: Continuing to revolutionise the life sciences value chain

After years of caution, the life sciences industry is embracing AI innovation and its wealth of opportunities.

Insights Creating the Digitally-Enabled Doctor

Overcoming barriers, and forging early wins, is vital to truly leverage the power of digital health.

Article AI in Life Sciences: Future-Proofing Strategies

Life sciences businesses must implement robust frameworks to manage AI. Here are the key steps to deploy AI successfully, manage outcomes, and safeguard against risks.

Article US remains heavily reliant on foreign medicine ingredients

China and India dominate medicine ingredient production, raising concerns over pharmaceutical supply chain resilience.